SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.01-2.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (11576)11/24/1997 8:32:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Andy, I agree with you that $20 is just around the corner. LGND has had good support around 13 3/4 and it sounds like the good news is about to come out. The NBC story on treating head and neck tumors with retinoids (ALRT1550?) is rather powerfull and probably represents the tip of the iceburg on such stories. A new SEC filing on ALRT is also a signal that the buyback is about to be finalized, paving the way for closure of the LLY deal and selction of the new compound. SA also incicated that the Panretin topical data would be out this year and I expect that to be a strong positive, paving the way for an NDA in 1Q 1998. There is quite a bit of news slated to come out, although more is now set for 1Q 1998 than 4Q 1997. LGND's current price is less than ideal, but considerably better than others. AMLN set a 52-week low last week, at 6 1/2. LGND and AMLN prices were very close before AMLN released Phase III data on Pramlintide. In contrast, I expect Panretin phase III data to be very favorable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext